天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> International Journal of Molecular Sciences >>article
International Journal of Molecular Sciences

International Journal of Molecular Sciences

IF: 5.59
Download PDF

Enrofloxacin—The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?

Published:26 March 2022 DOI: 10.3390/ijms23073648
?ukasz Grabowski,?Lidia Gaffke,?Karolina Pierzynowska,?Zuzanna Cyske,?Marta Choszcz,?G. W?grzyn,?A. W?grzyn

Abstract

Enrofloxacin is a compound that originates from a group of fluoroquinolones that is widely used in veterinary medicine as an antibacterial agent (this antibiotic is not approved for use as a drug in humans). It reveals strong antibiotic activity against both Gram-positive and Gram-negative bacteria, mainly due to the inhibition of bacterial gyrase and topoisomerase IV enzymatic actions. The high efficacy of this molecule has been demonstrated in the treatment of various animals on farms and other locations. However, the use of enrofloxacin causes severe adverse effects, including skeletal, reproductive, immune, and digestive disorders. In this review article, we present in detail and discuss the advantageous and disadvantageous properties of enrofloxacin, showing the benefits and risks of the use of this compound in veterinary medicine. Animal health and the environmental effects of this stable antibiotic (with half-life as long as 3–9 years in various natural environments) are analyzed, as are the interesting properties of this molecule that are expressed when present in complexes with metals. Recommendations for further research on enrofloxacin are also proposed.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Enrofloxacin 93106-60-6 C19H22FN3O3 650 suppliers $6.00-$2194.50

Similar articles

IF:13

Gatifloxacin: a review of its use in the treatment of bacterial infections in the US.

Drugs Susan J Keam, Katherine F Croom,etc Published: 1 January 2005
IF:1.8

Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.

Clinical ophthalmology Darlene Miller,etc Published: 1 March 2008
IF:6.8

The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in?vitro and in?vivo.

Journal of Ginseng Research Qi-rui Hu , Yao Pan ,etc Published: 1 March 2023